Layer 1
News | All clinical

Refine

E.g., 22/01/2022
E.g., 22/01/2022
The MHRA has also been reconsidering the use of valproate to treat bipolar disorders
The Department of Health and Social Care (DH) published its response to the Independent Medicines and Medical Devices Safety Review yesterday (July...
22/07/2021 4
EXCLUSIVE
EMA: Products resulting in exposure to 1mg-plus daily of boron, should not be used in under twos
Update (July 7) The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the benefits of chloramphenicol eye drops...
07/07/2021 3
EXCLUSIVE
Allevia 120mg tablets switched from POM to GSL in December 2020
On December 22, 2020, the Medicines Healthcare and Regulatory Authority (MHRA) published a public assessment report reclassifying hayfever tablets...
01/07/2021 6
It can be tricky to keep up with the news about COVID-19. To ease the process, C+D has collected a summary of all its coverage on the virus’s impact...
01/07/2021 10
The new batches for all strengths (50/100/200/250mcg) have been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and will...
24/06/2021 0
Pfizer: Working to solve Champix supply issues “with urgency”
The disruption in the supply of the smoking cessation medicine will “result in shortages with immediate effect”, a Pfizer spokesperson told C+D last...
18/06/2021 0
Fluoxetine has been the subject of the most SSPs since they were introduced in October 2019
The DH has not yet been “made aware of any concerns or negative effects on patient safety” related to the introduction of SSPs, it said in a one-year...
11/06/2021 2
MHRA: The increased availability of another nasal steroid spray would be useful to individuals
The 30 spray pack of Nasacort Allergy Relief for adults 55 micrograms/dose is “sufficiently safe to be sold on general sale”, the Medicines and...
03/06/2021 2
In a vaccine update posted earlier this month (May 6), Public Health England (PHE) said that from June 1 it will be supplying the pneumococcal...
27/05/2021 0
PSNC: We want to put the burden back on prescribers, as they should know the correct process
According to a Medicines and Healthcare products Regulation Agency (MHRA) guidance update on levothyroxine issued last week (May 19), healthcare...
26/05/2021 11

Pages